We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01498484
Brief Title: Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

First Submitted : December 21, 2011
First Submitted that Met QC Criteria : December 22, 2011
First Posted : December 23, 2011 (Estimate)

Results First Submitted : June 30, 2022
Results First Submitted that Met QC Criteria : September 26, 2022
Results First Posted : October 21, 2022

Certification/Extension First Submitted : July 8, 2020
Certification/Extension First Submitted that Met QC Criteria : July 8, 2020
Certification/Extension First Posted : July 10, 2020

Last Update Submitted that Met QC Criteria : September 26, 2022
Last Update Posted : October 21, 2022